PROGRAM AGENDA
6:15 PM Dinner and Networking
7:00 PM AML Introduction and Welcome
Jeffrey Lancet, MD & Lauren Berger, MPH
7:15 PM Effective use of molecular diagnostic data in AML therapeutic decision-
making
Maxim Norkin, MD, PhD
7:45 PM Management of the elderly patient with AML
Kendra Sweet, MD, MS &
Chetasi Talati, MD
8:15 PM Evolving role of FLT3 inhibitors and other targeted agents in AML
Julio Hajdenberg, MD, FACP &
Talia Zahra, MD
8:45 PM Informal case presentations from the audience with discussions by panelists
and others - Jeffrey Lancet, MD
9:00 PM Adjourn